SG11201701875YA - Methods for detecting ovarian cancer - Google Patents
Methods for detecting ovarian cancerInfo
- Publication number
- SG11201701875YA SG11201701875YA SG11201701875YA SG11201701875YA SG11201701875YA SG 11201701875Y A SG11201701875Y A SG 11201701875YA SG 11201701875Y A SG11201701875Y A SG 11201701875YA SG 11201701875Y A SG11201701875Y A SG 11201701875YA SG 11201701875Y A SG11201701875Y A SG 11201701875YA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- ovarian cancer
- detecting ovarian
- detecting
- cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
- G01N2405/08—Sphingolipids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20145855 | 2014-10-02 | ||
| PCT/FI2015/050654 WO2016051020A1 (en) | 2014-10-02 | 2015-10-02 | Methods for detecting ovarian cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201701875YA true SG11201701875YA (en) | 2017-04-27 |
Family
ID=55629471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201701875YA SG11201701875YA (en) | 2014-10-02 | 2015-10-02 | Methods for detecting ovarian cancer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10534001B2 (enExample) |
| EP (1) | EP3201623B1 (enExample) |
| JP (1) | JP6892820B2 (enExample) |
| KR (1) | KR20170061704A (enExample) |
| CN (1) | CN106716127B (enExample) |
| AU (1) | AU2015326756A1 (enExample) |
| BR (1) | BR112017006593A2 (enExample) |
| CA (1) | CA2959832A1 (enExample) |
| SG (1) | SG11201701875YA (enExample) |
| WO (1) | WO2016051020A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3351938A1 (en) | 2017-01-18 | 2018-07-25 | BIOCRATES Life Sciences AG | New biomarkers for assessing ovarian cancer |
| EP3649472A1 (en) | 2017-07-05 | 2020-05-13 | Zora Biosciences OY | Methods for detecting ovarian cancer |
| CN107656006A (zh) * | 2017-09-08 | 2018-02-02 | 上海市东方医院 | 用于检测血清或者血浆中α‑羟基丁酸浓度的试剂盒和方法 |
| CN108152430A (zh) * | 2017-12-21 | 2018-06-12 | 上海中科新生命生物科技有限公司 | 基于prm检测的卵巢癌标志物检测试剂盒及检测方法 |
| US20220137053A1 (en) * | 2019-01-30 | 2022-05-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Lipid biomarkers for cancer screening and monitoring |
| CN111430030A (zh) * | 2020-04-17 | 2020-07-17 | 武汉大学 | 生物标志物在卵巢癌评估中的应用方法及系统 |
| CN114544848B (zh) * | 2020-11-25 | 2023-04-28 | 中国科学院大连化学物理研究所 | 一种用于诊断卵巢上皮癌的血清脂质标志物组合物及试剂盒和其与应用 |
| EP4246146A1 (en) * | 2022-03-14 | 2023-09-20 | Fundació Institut Mar d'Investigacions Mèdiques (IMIM) | Method for diagnosing cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824555A (en) | 1996-05-30 | 1998-10-20 | The Cleveland Clinic Foundation | Method of detecting gynecological carcinomas |
| US20050054942A1 (en) * | 2002-01-22 | 2005-03-10 | Melker Richard J. | System and method for therapeutic drug monitoring |
| US20030180953A1 (en) * | 2000-12-29 | 2003-09-25 | Elitra Pharmaceuticals, Inc. | Gene disruption methodologies for drug target discovery |
| WO2003015436A1 (de) * | 2001-08-10 | 2003-02-20 | Siemens Aktiengesellschaft | Verfahren zum schnellen und lokalen fehlerbeheben beim ausfall einzelner physikalischer verbindungen in gebündelten kommunikationsverbindungen und kommunikationssystem-vorrichtung zum durchführen des verfahrens |
| US20040180387A1 (en) * | 2003-03-13 | 2004-09-16 | Fujirebio Diagnostics, Inc. | Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| US20050170441A1 (en) | 2003-09-12 | 2005-08-04 | Health Research, Inc. | Early detection of cancer of specific type using 1HNMR metabonomics |
| US20110246081A1 (en) * | 2007-10-15 | 2011-10-06 | Georgia Tech Research Corporation | Metabolomics-Based Identification of Disease-Causing Agents |
| GB2469244A (en) * | 2008-01-28 | 2010-10-06 | Univ Singapore | Lipid tumour profile |
| EP2279417B1 (en) | 2008-05-28 | 2016-07-20 | Georgia Tech Research Corporation | Metabolic biomarkers for ovarian cancer and methods of use thereof |
| JP4744618B2 (ja) * | 2009-04-13 | 2011-08-10 | シャープ株式会社 | ガス成分検出装置 |
| BRPI1016102A2 (pt) * | 2009-04-15 | 2015-09-01 | Sanford Burhnham Medical Res Inst | Inibidores de proteínas anti-apoptótica baseados em naftaleno |
| CA2778226A1 (en) * | 2009-10-09 | 2011-04-14 | Carolyn Slupsky | Methods for diagnosis, treatment and monitoring of patient health using metabolomics |
| US20110114511A1 (en) * | 2009-11-17 | 2011-05-19 | Sjong Angele | Apparatus for detecting volatile organic compounds and related methods |
| GB201016139D0 (en) | 2010-09-24 | 2010-11-10 | Univ Leuven Kath | Cancer phosholipidome |
| FI20115576A0 (fi) * | 2011-06-10 | 2011-06-10 | Teknologian Tutkimuskeskus Vtt Oy | Menetelmä Alzheimerin taudin diagnoimiseksi |
| WO2013016700A1 (en) | 2011-07-27 | 2013-01-31 | The Research Foundation Of State University Of New York | Methods for generating predictive models for epithelial ovarian cancer and methods for identifying eoc |
-
2015
- 2015-10-02 WO PCT/FI2015/050654 patent/WO2016051020A1/en not_active Ceased
- 2015-10-02 US US15/513,755 patent/US10534001B2/en active Active
- 2015-10-02 CN CN201580052938.0A patent/CN106716127B/zh active Active
- 2015-10-02 BR BR112017006593A patent/BR112017006593A2/pt not_active Application Discontinuation
- 2015-10-02 AU AU2015326756A patent/AU2015326756A1/en not_active Abandoned
- 2015-10-02 JP JP2017516994A patent/JP6892820B2/ja active Active
- 2015-10-02 KR KR1020177011691A patent/KR20170061704A/ko not_active Withdrawn
- 2015-10-02 SG SG11201701875YA patent/SG11201701875YA/en unknown
- 2015-10-02 CA CA2959832A patent/CA2959832A1/en not_active Abandoned
- 2015-10-02 EP EP15846140.0A patent/EP3201623B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2959832A1 (en) | 2016-04-07 |
| EP3201623A4 (en) | 2018-07-25 |
| US20170285036A1 (en) | 2017-10-05 |
| KR20170061704A (ko) | 2017-06-05 |
| JP6892820B2 (ja) | 2021-06-23 |
| BR112017006593A2 (pt) | 2017-12-19 |
| CN106716127A (zh) | 2017-05-24 |
| US10534001B2 (en) | 2020-01-14 |
| AU2015326756A1 (en) | 2017-05-11 |
| EP3201623B1 (en) | 2020-07-22 |
| JP2017535756A (ja) | 2017-11-30 |
| CN106716127B (zh) | 2020-12-08 |
| EP3201623A1 (en) | 2017-08-09 |
| WO2016051020A1 (en) | 2016-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201605660B (en) | Multispecific antibodies | |
| PL3227332T3 (pl) | Wielospecyficzne przeciwciała | |
| GB201414823D0 (en) | Multispecific antibodies | |
| GB201403489D0 (en) | Biomarkers for endometriosis | |
| GB201405151D0 (en) | Improved luggage apparatus | |
| GB201420842D0 (en) | Detector | |
| GB201408100D0 (en) | Detection method | |
| SG11201609350XA (en) | Methods for inhibiting necroptosis | |
| EP3201623A4 (en) | Methods for detecting ovarian cancer | |
| SG11201605070UA (en) | Novel methods for treating cancer | |
| GB201405203D0 (en) | Detecting apparatus | |
| SG11201702459VA (en) | Event-specific detection methods | |
| GB201508480D0 (en) | Cancer | |
| GB201416459D0 (en) | Detection method | |
| GB201420239D0 (en) | Biomarker | |
| GB201419330D0 (en) | Detection method | |
| GB201416015D0 (en) | Biomarker | |
| GB201411568D0 (en) | Detection | |
| IL247270B (en) | Method of detecting cancer | |
| SG11201702077RA (en) | Kit for cancer detection | |
| GB2537723B (en) | Apparatus for detecting approaching objects | |
| PL3210628T3 (pl) | Sposoby wytwarzania kompleksów fruktoboranowych | |
| GB201402174D0 (en) | Detection method | |
| HK1240648A1 (en) | Methods for detecting ovarian cancer | |
| GB201604813D0 (en) | Methods for detecting cancer |